sharecast

{{ storiesRelated.title }}

Stocks To Watch
28 Feb
wpp group chief executive martin sorrell
Thursday preview: WPP, US data barrage ahead

The market spotlight on Thursday is likely to again be on recently-appointed US central bank chief Jerome Powell, as he delivers the second part of his semi-annual testimony to Congress, this time before the Senate Banking Committee.

27 Feb
Weir Group, oil & gas services
Wednesday preview: Euro area inflation, Weir Group in the spotlight

The focus on Wednesday will shift back towards this side of the Pond, with the latest euro area consumer price data for the month of February possibly vindicating European Central Bank chief Mario Draghi's caution when it comes to potentially premature shifts in the Governing Council's policy bias.

26 Feb
le-senat-confirme-la-nomination-de-powell-a-la-tete-de-la-fed
Tuesday preview: Fed's Powell, StanChart in focus

All eyes on Tuesday will be on new US Federal Reserve chair Jerome Pewell, starting from 1500 GMT, as he delivers his semi-annual testimony before the House Financial Services' Committee on the central bank's latest monetary policy report to Congress.

22 Feb
Friday preview: Results from RBS, IAG, Pearson and William Hill

Royal Bank of Scotland on Friday will complete the week's series of high street banking results, accompanied by numbers from IAG, Pearson and William Hill.

21 Feb
serco
Thursday preview: Barclays, Centrica, Playtech and Serco results in focus

Continuing the series of banks reporting this week, Barclays results on Thursday come alongside those from Anglo American, BAE Systems, British American Tobacco, Centrica, Playtech, RSA Insurance and Serco.

15 Feb
Friday preview: Silver lining for UK retail sales, Segro results due

Data from the Office for National Statistics is unlikely to lift the dark clouds over UK retail but a better month is expected and could prove a thin ray of sunshine.

14 Feb
convatec woundcare
Thursday preview: US inflation data still in the spotlight

The flow of US data will be in focus again on Thursday, including multiple readings on different inflation gauges contained in a raft of economic indicators.

13 Feb
jerome powell federal
Wednesday preview: US inflation data 'key' to stock market correction

Tuesday's US inflation reading is seen as crucial to many traders and analysts, with eurozone GDP unlikely to surprise and UK company results coming from the likes of Galliford Try and Shire.

12 Feb
ep aviontui fly
Tuesday preview: UK inflation could surprise, Tui flies in with first quarter

Tuesday's business agenda includes UK inflation numbers, quarterly results from travel operator Tui and little else.

08 Feb
victrex, plastics
Friday preview: Industrial production, construction and trade in focus

Friday should be quite quiet after recent events, with Victrex the biggest name expected to provide a trading update ahead of UK industrial production numbers later in the morning.

07 Feb
mark carney portada
Thursday preview: What guidance will Bank of England give on rates?

The Bank of England's 'Super Thursday' is the main event of the week, while there are results and quarterly updates from the AA, Ashmore, Bellway, Compass, Smith & Nephew, Sophos, TalkTalk and Tate & Lyle.

06 Feb
Wednesday preview: GSK's results and consumer healthcare plans under the microscope

GlaxoSmithKline's full year results will be under the microscope on Wednesday with the shares down by a quarter from last year's summer highs, while there's plenty more for investors who want to focus on the fundamentals rather than the technical levels that were hammering global markets in recent sessions.

05 Feb
Tuesday preview: BP, Ocado results in focus

BP's results will be of interest to the many investors who bought back into the oil major's rally over the past couple of years, while Ocado will face investors on the back of a brace of major international deals.

01 Feb
bt openreach virtual reality vr
Friday preview: AstraZeneca looking to please, BT to avoid 'negative surprises'

As the first Friday of the month, the market agenda is dominated by US non-farm jobs report, while the main points on the UK calendar are construction data and results from AstraZeneca and BT Group.